Immix Biopharma Stock Market Value
| IMMX Stock | USD 1.72 0.07 3.91% |
| Symbol | Immix |
Immix Biopharma Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immix Biopharma. If investors know Immix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immix Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84) | Return On Assets (0.57) | Return On Equity (1.04) |
The market value of Immix Biopharma is measured differently than its book value, which is the value of Immix that is recorded on the company's balance sheet. Investors also form their own opinion of Immix Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Immix Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immix Biopharma's market value can be influenced by many factors that don't directly affect Immix Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immix Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immix Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immix Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immix Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immix Biopharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immix Biopharma.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Immix Biopharma on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Immix Biopharma or generate 0.0% return on investment in Immix Biopharma over 30 days. Immix Biopharma is related to or competes with ZyVersa Therapeutics, Hepion Pharmaceuticals, Cns Pharmaceuticals, Sonnet Biotherapeutics, Enveric Biosciences, Elevation Oncology, and Ocean Biomedical. Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therape... More
Immix Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immix Biopharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immix Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 32.68 | |||
| Value At Risk | (8.22) | |||
| Potential Upside | 7.06 |
Immix Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immix Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immix Biopharma's standard deviation. In reality, there are many statistical measures that can use Immix Biopharma historical prices to predict the future Immix Biopharma's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.14) |
Immix Biopharma Backtested Returns
Immix Biopharma holds Efficiency (Sharpe) Ratio of -0.0283, which attests that the entity had a -0.0283% return per unit of risk over the last 3 months. Immix Biopharma exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immix Biopharma's Market Risk Adjusted Performance of (0.13), standard deviation of 5.53, and Risk Adjusted Performance of (0.02) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.35, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immix Biopharma will likely underperform. At this point, Immix Biopharma has a negative expected return of -0.16%. Please make sure to check out Immix Biopharma's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Immix Biopharma performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.39 |
Below average predictability
Immix Biopharma has below average predictability. Overlapping area represents the amount of predictability between Immix Biopharma time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immix Biopharma price movement. The serial correlation of 0.39 indicates that just about 39.0% of current Immix Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.39 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Immix Biopharma lagged returns against current returns
Autocorrelation, which is Immix Biopharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immix Biopharma's stock expected returns. We can calculate the autocorrelation of Immix Biopharma returns to help us make a trade decision. For example, suppose you find that Immix Biopharma has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Immix Biopharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immix Biopharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immix Biopharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immix Biopharma stock over time.
Current vs Lagged Prices |
| Timeline |
Immix Biopharma Lagged Returns
When evaluating Immix Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immix Biopharma stock have on its future price. Immix Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immix Biopharma autocorrelation shows the relationship between Immix Biopharma stock current value and its past values and can show if there is a momentum factor associated with investing in Immix Biopharma.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immix Stock Analysis
When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.